Immunochemical faecal occult blood testing to screen for colorectal cancer: Can the screening interval be extended?
MetadataShow full item record
Objective: Colorectal cancer (CRC) screening programmes based on faecal immunochemical testing for haemoglobin (FIT) typically use a screening interval of 2 years. We aimed to estimate how alternative FIT strategies that use a lower than usual positivity threshold followed by a longer screening interval compare with conventional strategies. Methods: We analysed longitudinal data of 4523 Dutch individuals (50-74 years at baseline) participating in round I of a one-sample FIT screening programme, of which 3427 individuals also participated in round II after 1-3 years. The cohort was followed until 2 years after round II. In both rounds, a cut-off level of =50 ng haemoglobin (Hb)/mL buffer (corresponding to 10 mg Hb/g faeces) was used, representing the standard scenario. We determined the cumulative positivity rate (PR) and the numbers of subjects diagnosed with advanced adenomas (N_AdvAd) and early stage CRC (N_earlyCRC) in the cohort over two rounds of screening (standard scenario) and compared it with hypothetical single-round screening with use of a lower cut-off and omission of the second round (alternative scenario). Results: In the standard scenario, the cumulative (ie, round I and II combined) PR, N_AdvAd and N_earlyCRC were 13%, 180% and 26%, respectively. In alternative scenarios using a cut-off level of respectively =11 and =22 ng/HbmL buffer (corresponding to 2 and 4 mg Hb/g faeces), the PRs were 18% and 13%, the N_AdvAd were 180 and 162 and the N_earlyCRC ranged between 22-27 and 22-26. Conclusions: The diagnostic yield of FIT screening using a lowered positivity threshold in combination with an extended screening interval (up to 5 years) may be similar to conventional FIT strategies. This justifies and motivates further research steps in this direction.
Showing items related by title, author, creator and subject.
Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testingvan der Vlugt, M.; Grobbee, E.; Bossuyt, P.; Bos, A.; Bongers, E.; Spijker, W.; Kuipers, E.; Lansdorp_Vogelaar, Iris; Spaander, M.; Dekker, E. (2017)© 2017 AGA Institute Background & Aims Among subjects screened for colorectal cancer (CRC) by the guaiac fecal occult blood test, interval cancers develop in 48% to 55% of the subjects. Data are limited on how many ...
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screeningGoede, S.; Van Roon, A.; Reijerink, J.; Van Vuuren, A.; Lansdorp_Vogelaar, Iris; Habbema, J.; Kuipers, E.; Van Leerdam, M.; Van Ballegooijen, M. (2013)Objective The sensitivity and specificity of a single faecal immunochemical test (FIT) are limited. The performance of FIT screening can be improved by increasing the screening frequency or by providing more than one ...
Comparative economic evaluation of data from the ACRIN national CT colonography trial with three cancer intervention and surveillance modeling network microsimulationsVanness, D.; Knudsen, A.; Lansdorp_Vogelaar, Iris; Rutter, C.; Gareen, I.; Herman, B.; Kuntz, K.; Zauber, A.; Van Ballegooijen, M.; Feuer, E.; Chen, M.; Johnson, C. (2011)Purpose: To estimate the cost-effectiveness of computed tomographic (CT) colonography for colorectal cancer (CRC) screening in average-risk asymptomatic subjects in the United States aged 50 years. Materials and Methods: ...